Patient-Reported Outcomes (Pros) Of Cemiplimab Vs Chemotherapy In Advanced Non-Small Cell Lung Cancer (Ansclc): EMPOWER-Lung 1 Histology Subgroups

Files

128.pdf (103.91 KB)

Date

2022

Authors

URI

https://reader.elsevier.com/reader/sd/pii/S092375342203157X?token=CE440C703142DFD2F8552550E5FFE69B6C4BADA16CE67888407EC9305C61FAC843557A9FCF93829AF385621391C51EF6&originRegion=eu-west-1&originCreation=20230102074310
http://hdl.handle.net/11727/8489

Collections

Tıp Fakültesi / Faculty of Medicine
Wos Açık Erişimli Yayınlar
Wos İndeksli Yayınlar Koleksiyonu